Tetranectin in cerebrospinal fluid of patients with multiple sclerosis

References

• Holtet T. L., Graversen J. H., Clemmensen I., Thogersen H. C., Etzerodt M. Tetranectin, a trimeric plasminogen‐binding C‐type lectin. Protein Sci 1997; 6: 1511–15
   PubMedGoogle Scholar
• Clemmensen I., Petersen L. C., Kluft C. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin. Eur J Biochem 1986; 156: 327–33
   PubMedGoogle Scholar
• Christensen L., Johansen N., Jensen B. A., Clemmensen I. Immunohistochemical localization of a novel, human plasma protein, tetranectin, in human endocrine tissues. Histochemistry 1987; 87: 195–9
   PubMedGoogle Scholar
• Clemmensen I. Interaction of tetranectin with sulphated polysaccharides and trypan blue. Scand J Clin Lab Invest 1989; 49: 719–25
   PubMed Web of Science ®Google Scholar
• Lorentsen R. H., Graversen J. H., Caterer N. R., Thogersen H. C., Etzerodt M. The heparin–binding site in tetranectin is located in the N‐terminal region and binding does not involve the carbohydrate recognition domain. Biochem J 2000; 347 Pt 1: 83–7
   Google Scholar
• Kluft C., Jie A. F., Los P., de Wit E., Havekes L. Functional analogy between lipoprotein(a) and plasminogen in the binding to the kringle 4 binding protein, tetranectin. Biochem Biophys Res Commun 1989; 161: 427–33
   Google Scholar
• Caterer N. R., Graversen J. H., Jacobsen C., Moestrup S. K., Sigurskjold B. W., Etzerodt M., et al. Specificity determinants in the interaction of apolipoprotein(a) kringles with tetranectin and LDL. Biol Chem 2002; 383: 1743–50
   Google Scholar
• Kluft C., Los P., Clemmensen I. Calcium‐dependent binding of tetranectin to fibrin. Thromb Res 1989; 55: 233–8
   PubMed Web of Science ®Google Scholar
• De Vries T. J., De Wit P. E., Clemmensen I., Verspaget H. W., Weidle U. H., Brocker E. B., et al. Tetranectin and plasmin/plasminogen are similarly distributed at the invasive front of cutaneous melanoma lesions. J Pathol 1996; 179: 260–5
   PubMedGoogle Scholar
• Christensen L., Clemmensen I. Differences in tetranectin immunoreactivity between benign and malignant breast tissue. Histochemistry 1991; 95: 427–33
   PubMedGoogle Scholar
• Hogdall C. K., Christensen L., Clemmensen I. The prognostic value of tetranectin immunoreactivity and plasma tetranectin in patients with ovarian cancer. Cancer 1993; 72: 2415–22
   PubMed Web of Science ®Google Scholar
• Wewer U. M., Albrechtsen R. Tetranectin, a plasminogen kringle 4‐binding protein. Cloning and gene expression pattern in human colon cancer. Lab Invest 1992; 67: 253–62
   PubMedGoogle Scholar
• Obrist P., Spizzo G., Ensinger C., Fong D., Brunhuber T., Schafer G., et al. Aberrant tetranectin expression in human breast carcinomas as a predictor of survival. J Clin Pathol 2004; 57: 417–21
   PubMedGoogle Scholar
• Arvanitis D. L., Kamper E. F., Kopeikina L., Stavridou A., Sgantzos M. N., Kallioras V., et al. Tetranectin expression in gastric adenocarcinomas. Histol Histopathol 2002; 17: 471–5
   Google Scholar
• Hogdall C. K., Christensen L., Clemmensen I. The prognostic value of tetranectin immunoreactivity and plasma tetranectin in patients with ovarian cancer. Cancer 1993; 72: 2415–22
   PubMed Web of Science ®Google Scholar
• Hogdall C. K., Hogdall E. V., Hording U., Clemmensen I., Norgaard‐Pedersen B., Toftager‐Larsen K. Pre‐operative plasma tetranectin as a prognostic marker in ovarian cancer patients. Scand J Clin Lab Invest 1993; 53: 741–6
   PubMed Web of Science ®Google Scholar
• Obrist P., Spizzo G., Ensinger C., Fong D., Brunhuber T., Schafer G., et al. Aberrant tetranectin expression in human breast carcinomas as a predictor of survival. J Clin Pathol 2004; 57: 417–21
   PubMedGoogle Scholar
• Iba K., Durkin M. E., Johnsen L., Hunziker E., Damgaard‐Pedersen K., Zhang H., et al. Mice with a targeted deletion of the tetranectin gene exhibit a spinal deformity. Mol Cell Biol 2001; 21: 7817–25
   PubMedGoogle Scholar
• Wewer U. M., Ibaraki K., Schjorring P., Durkin M. E., Young M. F., Albrechtsen R. A potential role for tetranectin in mineralization during osteogenesis. J Cell Biol 1994; 127: 1767–5
   PubMed Web of Science ®Google Scholar
• Clemmensen I., Petersen L. C., Kluft C. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma:tetranectin. Eur J Biochem 1986; 156: 327–33
   PubMedGoogle Scholar
• Westergaard U. B., Andersen M. H., Heegaard C. W., Fedosov S. N., Petersen T. E. Tetranectin binds hepatocyte growth factor and tissue‐type plasminogen activator. Eur J Biochem 2003; 270: 1850–4
   PubMedGoogle Scholar
• Christensen L., Clemmensen I. Tetranectin immunoreactivity in normal human tissues. An immunohistochemical study of exocrine epithelia and mesenchyme. Histochemistry 1989; 92: 29–35
   PubMedGoogle Scholar
• Borregaard N., Christensen L., Bejerrum O. W., Birgens H. S., Clemmensen I. Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase. J Clin Invest 1990; 85: 408–16
   PubMed Web of Science ®Google Scholar
• Stoevring B., Jaliashvili I., Thougaard A. V., Ensinger C., Hogdall C. K., Rasmussen L. S., et al. Tetranectin in cerebrospinal fluid: biochemical characterisation and evidence of intrathecal synthesis or selective uptake into CSF. Clin Chim Acta 2005; 359: 65–71
   Google Scholar
• Dietzmann K., von Bossanyi P., Krause D., Wittig H., Mawrin C., Kirches E. Expression of the plasminogen activator system and the inhibitors PAI‐1 and PAI‐2 in posttraumatic lesions of the CNS and brain injuries following dramatic circulatory arrests: an immunohistochemical study. Pathol Res Pract 2000; 196: 15–21
   Google Scholar
• Liu X. D., Zeng B. F., Xu J. G., Zhu H. B., Xia Q. C. Proteomic analysis of the cerebrospinal fluid of patients with lumbar disk herniation. Proteomics 2006; 1019–28
   Google Scholar
• Hammack B. N., Fung K. Y., Hunsucker S. W., Duncan M. W., Burgoon M. P., Owens G. P., et al. Proteomic analysis of multiple sclerosis cerebrospinal fluid. Multiple Sclerosis 2004; 10: 245–60
   PubMed Web of Science ®Google Scholar
• Poser C. M., Paty D. W., Scheinberg L., McDonald W. I., Davis F. A., Ebers G. C., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227–31
   PubMed Web of Science ®Google Scholar
• Hogdall C. K., Hogdall E. V., Hording U., Daugaard S., Clemmensen I., Norgaard‐Pedersen B., et al. Plasma tetranectin and ovarian neoplasms. Gynecol Oncol 1991; 43: 103–7
   PubMed Web of Science ®Google Scholar
• Clemmensen I., Lund L. R., Christensen L., Andreasen P. A. A tetranectin‐related protein is produced and deposited in extracellular matrix by human embryonal fibroblasts. Eur J Biochem 1991; 195: 735–41
   PubMedGoogle Scholar
• Clemmensen I., Petersen L. C., Kluft C. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin. Eur J Biochem 1986; 156: 327–33
   PubMedGoogle Scholar
• Jensen B. A., McNair P., Hyldstrup L., Clemmensen I. Plasma tetranectin in healthy male and female individuals, measured by enzyme‐linked immunosorbent assay. J Lab Clin Med 1987; 110: 612–17
   PubMed Web of Science ®Google Scholar
• Sellebjerg F., Christiansen M. Qualitative assessment of intrathecal IgG synthesis by isoelectric focusing and immunodetection: interlaboratory reproducibility and interobserver agreement. Scand J Clin Lab Invest 1996; 56: 135–43
   PubMed Web of Science ®Google Scholar
• Pereira E., Tamia‐Ferreira M. C., Cardoso R. S., Mello S. S., Sakamoto‐Hojo E. T., Passos G. A., et al. Immunosuppressive therapy modulates T lymphocyte gene expression in patients with systemic lupus erythematosus. Immunology 2004; 113: 99–105
   PubMedGoogle Scholar
• Borregaard N., Christensen L., Bejerrum O. W., Birgens H. S., Clemmensen I. Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase. J Clin Invest 1990; 85: 408–16
   PubMed Web of Science ®Google Scholar